Viewing nowVildagliptin Tablets 50 mg (Vildagliptin)
Vildagliptin 50mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

MFDS item code 202102255 · Approved 2021.03.12 · Insurance code 622804670
Improvement of glycemic control in type 2 diabetes mellitus
This medication assists patients with type 2 diabetes in managing blood sugar levels in conjunction with dietary and exercise therapies. It can be used alone or in combination with other medications to effectively manage blood sugar. This helps stabilize blood glucose levels and contributes to maintaining a healthy lifestyle.
For monotherapy, or when used in combination with metformin in patients with no prior experience of antidiabetic drug therapy, administer 50mg once daily in the morning or 100mg daily, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with metformin or a thiazolidinedione as monotherapy, the recommended dose when this medicine is used in combination with metformin or a thiazolidinedione is 100mg daily, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with a sulfonylurea as monotherapy, the recommended dose when this medicine is used in combination with a sulfonylurea is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. When adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose when this medicine is used in combination (as triple therapy) is 100mg daily, divided into 50mg twice daily in the morning and evening. When adequate glycemic control cannot be achieved with insulin therapy (insulin alone or in combination with metformin), the recommended dose when this medicine is used in combination is 100mg daily, divided into 50mg twice daily in the morning and evening. This medicine may be taken with or without food, and doses above 100mg daily are not recommended. When this medicine is used in combination with a sulfonylurea, a reduction in the sulfonylurea dose may be necessary to reduce the risk of hypoglycemia. If you forget to take this medicine, take it as soon as you remember and take the next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment: This medicine is not recommended for patients with hepatic impairment whose ALT or AST levels before treatment exceed 2.5 times the upper limit of normal. Mild renal impairment (creatinine clearance ≥50mL/min): No dose adjustment is necessary. Moderate or severe renal impairment or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended.
This medication should not be used by patients who are allergic to specific ingredients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with lactose intolerance or specific genetic metabolic disorders should also not use this medication. During treatment, liver function abnormalities may occur, so regular liver function tests are necessary. If liver function tests show severely elevated levels, the medication should be discontinued and not restarted until liver function is restored. Care should be exercised in some patients with heart failure, and use should not be recommended in cases of severe heart failure. If skin blistering or ulceration occurs, immediate consultation with a physician is necessary. There is a risk of acute pancreatitis, so if symptoms of pancreatitis appear, the medication should be stopped and healthcare personnel should be notified. When used with other diabetes medications that can cause hypoglycemia, there may be an increased risk of hypoglycemia, necessitating dosage adjustments. If symptoms such as dizziness occur, it is advisable to avoid driving or operating machinery. Severe joint pain may occur, so consideration should be given to stopping the medication if such symptoms arise. Pregnant or breastfeeding women should not use this medication for safety reasons. While no special dosage adjustments are required for the elderly, use is not recommended for children or adolescents under the age of 18. In cases of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, as the medication is not removed by hemodialysis. The medication should be stored in a safe place out of the reach of children, and it should not be transferred to other containers.
Hepatitis, liver dysfunction, elevated transaminase levels, angioedema, tremors, headache, dizziness, fatigue, nausea, hypoglycemia, pharyngitis, weakness, constipation, weight gain, peripheral edema, gastroesophageal reflux, diarrhea, bloating, chills, reduced blood sugar, sweating, pancreatitis, urticaria, blisters, exfoliative skin lesions, arthralgia with severe and disability symptoms, cutaneous vasculitis, cholecystitis, upper respiratory infection, acute myocardial infarction, nodal arrhythmia, acute cholecystitis, pneumothorax, cholelithiasis, femoral fracture, peripheral artery occlusive disease, supraventricular tachycardia, congestive heart failure, gastric ulcer, gastric cancer, increased INR, appendicitis, pulmonary edema, dizziness, chest discomfort, shortness of breath, cough, dyspepsia, drowsiness, pruritus, dry mouth, vomiting, insomnia, kidney dysfunction, lip blisters, hunger, sensory impairment, spinal canal stenosis, abdominal pain, gastroenteritis, gastritis, gastric ulcer, belching, fatty liver, hyperkalemia, hypertriglyceridemia, heart failure, cardiomegaly, angina, cardiac arrest, renal cyst, lung cancer, leg pain, increased C-reactive protein, vesicular pemphigoid, myalgia, paresthesia, fever, edema, elevated lipase levels, elevated creatine phosphokinase levels, increased C-reactive protein, elevated myoglobin levels
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and moisture, so it should be stored in a sealed container. Additionally, it should be kept in a cool place below 30 degrees Celsius to maintain its effectiveness.
White to light yellow round tablets
30 tablets/box [(10 tablets/Alu-Alu*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowVildagliptin 50mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Ahn-Guk New Pharm Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
AhnGuk Pharmaceuticals Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Lightpharmtech Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
White Life Sciences Co., Ltd.
Vildagliptin 50mg
Tablet · Prescription medication
Pharmgen Science Co., Ltd.

Vildagliptin 50mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.